2-(isopropylthio)benzoic acid | 41394-95-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(isopropylthio)benzoic acid
• 英文别名: 2-isopropylsulfanylbenzoic acid；2-propan-2-ylsulfanylbenzoic acid
• CAS: 41394-95-0
• 化学式: C₁₀H₁₂O₂S
• mdl: MFCD07364761
• 分子量: 196.27
• InChiKey: CHFNTLOTIFQVGQ-UHFFFAOYSA-N

物化性质

• 熔点：
  117 °C(Solv: hexane (110-54-3))
• 沸点：
  316.2±25.0 °C(Predicted)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  62.6
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2930909090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(Isopropylsulfanyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(Isopropylsulfanyl)benzoic acid
CAS number: 41394-95-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12O2S
Molecular weight: 196.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(isopropylthio)benzoic acid 在 碘苯二乙酸 、 四乙基溴化铵 作用下， 以 乙腈 为溶剂， 以73 %的产率得到2,2-dimethyl-4H-3,1-benzoxathiin-4-one
  参考文献：
  名称：

  通过醚和硫醚的 α-Csp3-H 活化实现无过渡金属的脱氢环化

  摘要：

  我们在此报道了四乙基溴化铵催化 O- 或 S- 烷基化水杨酸或硫代水杨酸衍生物的分子内氧化环化以获得 4 H -苯并[ d ] [1,3] 二恶英-4-酮或 4 H -苯并[ d ] [ 1,3]oxathiin-4-ones，分别。水杨酸衍生物的氧化环化在 110 °C 通过自由基途径进行。相反，硫代水杨酸的环化在室温下通过离子途径顺利进行。值得注意的是，整体反应速度快，反应时间短，产品收率高，季碳中心形成顺利。

  DOI：

  10.1055/a-2017-6065
• 作为产物：
  描述：

  isopropyl (2-isopropylthio)benzoate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 5.0h， 以85%的产率得到2-(isopropylthio)benzoic acid
  参考文献：
  名称：

  Black, Michael; Cadogan, J. I. G.; McNab, Hamish, Journal of the Chemical Society. Perkin transactions I, 1994, # 2, p. 155 - 160

  摘要：

  DOI：

文献信息

• Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
  作者：Marco Migliore、Silvia Pontis、Angel Luis Fuentes de Arriba、Natalia Realini、Esther Torrente、Andrea Armirotti、Elisa Romeo、Simona Di Martino、Debora Russo、Daniela Pizzirani、Maria Summa、Massimiliano Lanfranco、Giuliana Ottonello、Perrine Busquet、Kwang-Mook Jung、Miguel Garcia-Guzman、Roger Heim、Rita Scarpelli、Daniele Piomelli

  DOI：10.1002/anie.201603746

  日期：2016.9.5

  intracellular cysteine amidase, N‐acylethanolamine acid amidase (NAAA). Even though NAAA may offer a new target for anti‐inflammatory therapy, the lipid‐like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs. A series of novel benzothiazole–piperazine derivatives that inhibit NAAA in a potent and selective manner by a non‐covalent mechanism are

  棕榈酰乙醇酰胺（PEA）和油酰乙醇酰胺（OEA）是抑制炎症的内源性脂质介体。它们的作用被细胞内半胱氨酸酰胺酶，N-酰基乙醇胺酸酰胺酶（NAAA）终止。尽管NAAA可能为抗炎治疗提供新的靶标，但目前NAAA抑制剂的类脂质结构和反应弹头限制了将这些试剂用作口服药物。描述了一系列通过非共价机制有效和选择性抑制NAAA的新型苯并噻唑-哌嗪衍生物。此类的原型成员（8）在多发性硬化症（MS）的小鼠模型中显示出较高的口服生物利用度，可进入中枢神经系统（CNS）的功能以及强大的活动。该化合物是第二代非共价NAAA抑制剂的例证，可用于治疗MS和其他慢性CNS疾病。
• Dioxanes and uses thereof
  申请人：——

  公开号：US20040072849A1

  公开（公告）日：2004-04-15

  In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I): 1 and pharmaceutically acceptable derivatives thereof, wherein R 1 , R 2 , R 3 , n, X and Y are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The present invention further provides compounds capable of inhibiting histone deacetylatase activity and methods for treating disorders regulated by histone deacetylase activity (e.g., cancer and protozoal infections) comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. The present invention additionally provides methods for modulating the glucose-sensitive subset of genes downstream of Ure2p. The present invention also provides methods for preparing compounds of the invention.

  鉴于需要开发新型治疗剂和有效的合成方法，本发明提供了一般式(I)的新化合物： 1 及其药学上可接受的衍生物，其中R 1 ，R 2 ，R 3 ，n，X和Y如本文所定义。本发明还提供了包含一种式(I)化合物和药学上可接受的载体的药物组合物。本发明还提供了能够抑制组蛋白去乙酰化酶活性的化合物以及治疗由组蛋白去乙酰化酶活性调节的疾病的方法（例如，癌症和原虫感染），包括向需要的受体施用一种式(I)化合物的治疗有效量。本发明还提供了调节Ure2p下游葡萄糖敏感基因子集的方法。本发明还提供了制备本发明化合物的方法。
• Interrupted Pummerer Reaction in Latent‐Active Glycosylation: Glycosyl Donors with a Recyclable and Regenerative Leaving Group
  作者：Penghua Shu、Xiong Xiao、Yueqi Zhao、Yang Xu、Wang Yao、Jinyi Tao、Hao Wang、Guangmin Yao、Zimin Lu、Jing Zeng、Qian Wan

  DOI：10.1002/anie.201507861

  日期：2015.11.23

  Latent O‐glycosides, 2‐(2‐propylthiol)benzyl (PTB) glycosides, were converted into the corresponding active glycosyl donors, 2‐(2‐propylsulfinyl)benzyl (PSB) glycosides, by a simple and efficient oxidation. Treatment of the PSB donor and various acceptors with triflic anhydride provided the desired glycosides in good to excellent yields. The leaving group, which was activated by an interrupted Pummerer

  通过简单而有效的氧化，将潜在的O-糖苷2-（2-丙基硫醇）苄基（PTB）糖苷转化为相应的活性糖基供体2-（2-丙基亚磺酰基）苄基（PSB）糖苷。用三氟甲磺酸酐处理PSB供体和各种受体可提供所需糖苷，收率良好至极佳。可以通过Pummerer反应中断而激活的离去基团可以循环（PSB-OH）并再生为前体（PTB-OH）。用这种新开发的方法，以收敛的[3 + 1]方式有效地合成了天然的保护肝脏的糖苷，莱诺糖苷F。本发明的总合成也导致该苯乙酮类糖苷的结构改变。
• Amide inhibitors of microsomal triglyceride transfer protein
  申请人：——

  公开号：US20020156281A1

  公开（公告）日：2002-10-24

  The present invention provides compounds having the Formula I 1 The present invention also provides pharmaceutical compositions comprising a compound of Formula I and methods of treatment of atherosclerosis, obesity, restenosis, coronary heart disease, hyperlipoproteinemia, hypercholesterolemia, and hypertriglyceridemia.

  本发明提供具有化学式I的化合物。本发明还提供包含化合物I的药物组合物，以及治疗动脉粥样硬化、肥胖症、再狭窄、冠心病、高脂蛋白血症、高胆固醇血症和高甘油三酯血症的方法。
• Formation of dibenzofurans by flash vacuum pyrolysis of aryl 2-(allyloxy)benzoates and related reactions
  作者：Michael Black、J. I. G. Cadogan、Hamish McNab

  DOI：10.1039/c002480e

  日期：——

  Flash vacuum pyrolysis (FVP) of aryl 2-(allyloxy)benzoates 5 and of the corresponding aryl 2-(allylthio)benzoates 6 at 650 °C, gives dibenzofurans 19 and dibenzothiophenes 20, respectively. The mechanism involves generation of phenoxyl (or thiophenoxyl) radicals by homolysis of the O-allyl (or S-allyl) bond, followed by ipso attack at the ester group, loss of CO2 and cyclisation of the resulting aryl

  在650℃下，对 2-（烯丙氧基）苯甲酸芳基酯5和相应的2-（烯丙硫基）苯甲酸芳基酯6进行快速真空热解（FVP），分别得到二苯并呋喃19和二苯并噻吩20。该机制涉及产生苯氧基 （或者 噻吩氧基）通过O-烯丙基（或小号烯丙基）键，然后在酯基上进行ipso攻击，CO 2损失和所得芳基自由基环化。综合而言，该方法对p-取代的底物效果很好，可产生2-取代的二苯并呋喃19b-f（73-90％）和二苯并噻吩20b-c（90-94％）。在m-取代的底物的环化以及自由基与取代基和ipso-攻击的竞争性相互作用中，几乎没有选择性显示出o取代的底物的热解复杂化。相关自由基前体的FVP包括2-（烯丙氧基）苯基苯甲酸酯43没有产生二苯并呋喃，而2-（烯丙氧基-5-甲基）偶氮苯 44降低了产量。通过FVP不能获得咔唑2-（烯丙基氨基）苯甲酸4-甲基苯酯 42。